Author:
Gonzalez-Vivo Maria,Zugazaga Ander,Cusco Josep Maria Dedeu,Naranjo-Hans Dolores,Casajoana Anna,Carot Laura
Reference18 articles.
1. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors;Scarpa;Journal of Surgical Oncology,2008
2. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden;Nilsson;Cancer,2005
3. “The SCARE guidelines: Consensus-based surgical case report guidelines” [Int. J. Surg. 34 (2016) 180–186]((2016) 34 (180–186)(S174391911630303X)(10.1016/j.ijsu.2016.08.014));Agha;International Journal of Surgery,2016
4. Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era;van der Graaf;Br. J. Surg.,2018
5. The histopathological differential diagnosis of gastrointestinal stromal tumours;Graadt van Roggen;Journal of Clinical Pathology,2001